Compare Stocks

CyberAgent, Inc. engages in the media, internet advertising, game, and investment development businesses primarily in Japan. The company operates Ameba, a blog service; Tapple for online dating; AWA, a music streaming service; and WinTicket for online betting. It also offers internet advertising agency and ad technology services; and smartphone games. In addition, the company operates a programming school for kids and provides application and reward points exchange platform services; artificial intelligence services; and digital transformation services. CyberAgent, Inc. was incorporated in 1998 and is headquartered in Tokyo, Japan.

Dai Nippon Printing Co., Ltd. primarily engages in the printing business. The company's Information Communication segment offers books, including standard books, textbooks, dictionaries, e-books, and commemorative and memorial editions; magazines; digital marketing support services; BPR consulting and BPO services; information processing services; smart cards, payment-related services, card-related equipment, authentication and security services; and IC tags, holograms, business forms, catalogs, leaflets, brochures, calendars, point-of-purchase materials, and digital signage products, as well as operates events, stores, and contents. This segment also offers dye-sublimation thermal transfer materials; and thermal resin-type transfer printing media, as well as engages in the ID photo booth business; entertainment and amuse photo solutions; e-books sales and distribution; book sales; and library management. Its Lifestyle and Industrial Supplies segment provides packaging materials for products, such as foods, beverages, snacks, household items and medical supplies, cups, plastic bottles, laminated tubes, molded plastic containers, aseptic filling systems; interior and exterior materials for homes, stores, offices, vehicles, home appliances, and furniture; molded plastic parts for automobiles and metallic veneers; lithium-ion battery components; photovoltaic module components; transporting electronic component materials; and multifunctional insulation boxes. The company's Electronics segment offers optical films for displays; projection screens; metal masks; photomasks for making liquid crystal displays, touch panel components, and semiconductor products; lead frames; LSI design; hard disk suspensions; electronic modules; and micro electro mechanical systems. Its Beverages segment produces and sells carbonated, coffee, tea, fruit juice, functional, mineral water, and alcoholic beverages, etc. The company was founded in 1876 and is headquartered in Tokyo, Japan.

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

abrdn plc provides asset management services in the United Kingdom, Europe, North America, and Asia. The company offers investment solutions and funds; long-term savings and investment products to individual and corporate customers; and life insurance and savings products. It provides its products through institutional, wholesale, and retail distribution channels. It also makes real estate investments. The company was formerly known as Standard Life Aberdeen plc. abrdn plc was founded in 1825 and is headquartered in Edinburgh, United Kingdom.

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.